These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8095699)

  • 1. Porphyrin metabolism abnormalities and its treatment in a uremic patient with porphyria cutanea tarda.
    Yasuda G; Ikeda Y; Satta H; Shionoiri H; Ishii M; Ikezawa Y
    Nephron; 1993; 63(2):235-6. PubMed ID: 8095699
    [No Abstract]   [Full Text] [Related]  

  • 2. Salivary porphyrin concentration in porphyria cutanea tarda.
    Moran MJ; Santos JL; Fontanellas A; Sepulveda P; Enriquez de Salamanca R
    J Dermatol Sci; 1993 Oct; 6(2):155-8. PubMed ID: 7903863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anesthetic management with propofol in a case of porphyria cutanea tarda].
    García-Galán F; Pensado A; Luengo A; Roca E; Cabrero Y
    Rev Esp Anestesiol Reanim; 1994; 41(2):124-5. PubMed ID: 7913769
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis C virus and human immunodeficiency virus infection can alter porphyrin metabolism and lead to porphyria cutanea tarda.
    Blauvelt A
    Arch Dermatol; 1996 Dec; 132(12):1503-4. PubMed ID: 8961882
    [No Abstract]   [Full Text] [Related]  

  • 5. Correlation between levels of free and protein-bound plasma porphyrin and urinary porphyrins in porphyria cutanea tarda.
    Moran MJ; Fontanellas A; Santos JL; Enriquez de Salamanca R
    Int J Biochem Cell Biol; 1995 Jun; 27(6):585-8. PubMed ID: 7671136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of viral infection in porphyria cutanea tarda.
    Lim HW
    Photodermatol Photoimmunol Photomed; 1997 Jun; 13(3):75-7. PubMed ID: 9372518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Porphyrin abnormalities in acquired immunodeficiency syndrome.
    O'Connor WJ; Murphy GM; Darby C; Fogarty J; Mulcahy F; O'Moore R; Barnes L
    Arch Dermatol; 1996 Dec; 132(12):1443-7. PubMed ID: 8961872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hepatobiliary disease, chronic hepatitis C and hepatitis B virus infections and interferon-alpha on porphyrin profiles in plasma, urine and faeces.
    Gibson PR; Grant J; Cronin V; Blake D; Ratnaike S
    J Gastroenterol Hepatol; 2000 Feb; 15(2):192-201. PubMed ID: 10735544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P450 induction, uroporphyrinogen decarboxylase depression, porphyrin accumulation and excretion, and gender influence in a 3-week rat model of porphyria cutanea tarda.
    Franklin MR; Phillips JD; Kushner JP
    Toxicol Appl Pharmacol; 1997 Dec; 147(2):289-99. PubMed ID: 9439724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alcohol and its effect on porphyrin metabolism].
    Krivosheev BN; Krivosheev AB
    Ter Arkh; 1994; 66(2):32-6. PubMed ID: 7909174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathogenesis of porphyria cutanea tarda].
    Kószó F; Simon M
    Orv Hetil; 2000 Apr; 141(14):709-13. PubMed ID: 10803012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of new porphyrin metabolites in human porphyria cutanea tarda and in rats treated with hexachlorobenzene by HPTLC, HPLC and liquid secondary ion mass spectrometry.
    Luo J; Lim CK
    Biomed Chromatogr; 1995; 9(3):113-22. PubMed ID: 7655298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal urinary coproporphyrin levels in patients infected by hepatitis C virus with or without human immunodeficiency virus. A study of 177 patients.
    Cribier B; Rey D; Uhl G; Le Coz C; Hirth C; Libbrecht E; Vetter D; Lang JM; Stoll-Keller F; Grosshans E
    Arch Dermatol; 1996 Dec; 132(12):1448-52. PubMed ID: 8961873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porphyrin metabolism in porphyria metabolism in porphyria cutanea tarda.
    IPPEN H
    Panminerva Med; 1962 Sep; 4():381-2. PubMed ID: 13956662
    [No Abstract]   [Full Text] [Related]  

  • 15. Bullous dermatosis of end-stage renal disease: a possible association between abnormal porphyrin metabolism and aluminium.
    Gafter U; Mamet R; Korzets A; Malachi T; Schoenfeld N
    Nephrol Dial Transplant; 1996 Sep; 11(9):1787-91. PubMed ID: 8918623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between porphyria cutanea tarda and beta-thalassemia major.
    Barbieri L; Macrì A; Lupia Palmieri G; Aurizi C; Biolcati G
    Cell Mol Biol (Noisy-le-grand); 2009 Jul; 55(2):36-9. PubMed ID: 19656449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of hepatitis C virus (HCV) infection on porphyrin and iron metabolism in porphyria cutanea tarda (PCT) patients.
    Dabrowska E; Jabłońska-Kaszewska I; Bielawski KP; Falkiewicz B
    Med Sci Monit; 2001 May; 7 Suppl 1():190-6. PubMed ID: 12211718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The difference in liver pathology between sporadic and familial forms of porphyria cutanea tarda: the role of iron.
    Siersema PD; Rademakers LH; Cleton MI; ten Kate FJ; de Bruijn WC; Marx JJ; Wilson JH
    J Hepatol; 1995 Sep; 23(3):259-67. PubMed ID: 8550989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porphyrins, porphyrin metabolism, porphyrias. III. Diagnosis, care and monitoring in porphyria cutanea tarda--suggestions for a handling programme.
    Thunell S; Harper P
    Scand J Clin Lab Invest; 2000 Nov; 60(7):561-79. PubMed ID: 11202050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Porphyria cutanea tarda.
    Khoo BP; Tay YK
    Singapore Med J; 2000 Jun; 41(6):292-4. PubMed ID: 11109347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.